Astera Labs (NASDAQ:ALAB) Rating Increased to Moderate Buy at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of Astera Labs (NASDAQ:ALAB) to a moderate buy rating in a report released on Wednesday,Zacks.com reports.

ALAB has been the topic of several other research reports. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. BNP Paribas began coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Finally, Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Trading Up 3.1%

Shares of NASDAQ ALAB opened at $179.81 on Wednesday. The company has a market cap of $30.37 billion, a price-to-earnings ratio of 164.63, a PEG ratio of 2.35 and a beta of 1.50. Astera Labs has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a 50-day moving average price of $159.47 and a two-hundred day moving average price of $165.12.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s revenue was up 103.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the sale, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. This represents a 5.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel directly owned 147,040 shares of the company’s stock, valued at $21,275,217.60. This represents a 3.05% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the business. Cherry Creek Investment Advisors Inc. increased its stake in shares of Astera Labs by 5.5% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 3,854 shares of the company’s stock valued at $641,000 after acquiring an additional 200 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in Astera Labs by 30.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 7,794 shares of the company’s stock valued at $1,297,000 after purchasing an additional 1,819 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Astera Labs by 25.2% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 554,444 shares of the company’s stock valued at $99,556,000 after purchasing an additional 111,502 shares during the period. MOR Wealth Management LLC acquired a new position in shares of Astera Labs during the fourth quarter valued at about $294,000. Finally, Redhawk Wealth Advisors Inc. bought a new position in shares of Astera Labs during the 4th quarter worth about $246,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.